NEW YORK, July 2, 2020 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of MEI Pharma, Inc. ("MEI Pharma" or the "Company") (NASDAQ: MEIP). Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 7980. The...
from PR Newswire: https://ift.tt/31FNg9a
No comments:
Post a Comment